Targeted Medical
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; slee… Read more
Targeted Medical (TRGM) - Total Assets
Latest total assets as of December 2015: $2.43 Million USD
Based on the latest financial reports, Targeted Medical (TRGM) holds total assets worth $2.43 Million USD as of December 2015.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Targeted Medical - Total Assets Trend (2008–2015)
This chart illustrates how Targeted Medical’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Targeted Medical - Asset Composition Analysis
Current Asset Composition (December 2015)
Targeted Medical's total assets of $2.43 Million consist of 34.3% current assets and 65.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.4% |
| Accounts Receivable | $467.50K | 19.3% |
| Inventory | $92.19K | 3.8% |
| Property, Plant & Equipment | $54.34K | 2.2% |
| Intangible Assets | $1.54 Million | 63.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2015)
This chart illustrates how Targeted Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Targeted Medical's current assets represent 34.3% of total assets in 2015, a decrease from 96.4% in 2008.
- Cash Position: Cash and equivalents constituted 3.4% of total assets in 2015, down from 7.7% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, an increase from 1.0% in 2008.
- Asset Diversification: The largest asset category is intangible assets at 63.4% of total assets.
Targeted Medical Competitors by Total Assets
Key competitors of Targeted Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Targeted Medical - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Targeted Medical generates 2.17x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Targeted Medical is currently not profitable relative to its asset base.
Targeted Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.06 | 0.04 | 2.60 |
| Quick Ratio | 0.05 | 0.03 | 2.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-13.84 Million | $ -11.82 Million | $ 15.42 Million |
Targeted Medical - Advanced Valuation Insights
This section examines the relationship between Targeted Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -2.9% |
| Total Assets | $2.43 Million |
| Market Capitalization | $1.16K USD |
Valuation Analysis
Below Book Valuation: The market values Targeted Medical's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Targeted Medical's assets decreased by 2.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Targeted Medical (2008–2015)
The table below shows the annual total assets of Targeted Medical from 2008 to 2015.
| Year | Total Assets | Change |
|---|---|---|
| 2015-12-31 | $2.43 Million | -2.93% |
| 2014-12-31 | $2.50 Million | -49.97% |
| 2013-12-31 | $5.00 Million | -52.98% |
| 2012-12-31 | $10.63 Million | +18.39% |
| 2011-12-31 | $8.98 Million | +53.09% |
| 2010-12-31 | $5.86 Million | -63.76% |
| 2009-12-31 | $16.18 Million | +53.57% |
| 2008-12-31 | $10.54 Million | -- |